Anti-signal recognition particle antibody-positive immune-mediated necrotizing myopathy treated with ofatumumab.
Autor: | Wen C; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China., Yang J; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China., Wei D; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China., Xu C; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China., Yu P; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China., Luo L; Department of Neurology, Wuhan No. 1 Hospital, Wuhan, Hubei, China. |
---|---|
Jazyk: | angličtina |
Zdroj: | Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Feb 01; Vol. 63 (2), pp. e53-e55. |
DOI: | 10.1093/rheumatology/kead424 |
Databáze: | MEDLINE |
Externí odkaz: |